Unilabs Middle East, a leading international provider of diagnostic services, has announced the integration of the Hologic Genius Digital Diagnostics System into its advanced cervical cancer laboratory services, making the UAE the first country in the Middle East to offer this groundbreaking technology.
The state-of-the-art system is the first digital cytology solution to combine the power of deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology.
The Genius Digital Diagnostics System is designed to transform cervical cancer detection by accurately identifying pre-cancerous lesions and cancerous cells in women with exceptional precision.
The system transforms the workflow from slide to screen, delivering unparalleled efficiency, collaboration, and diagnostic insights for enhanced patient care. It allows for secure storage and remote case reviews, ensuring seamless and efficient analysis for medical professionals.
Promoting UAE’s global position
The launch of this innovative system by Unilabs Middle East represents a step forward in the UAE’s health sector, reinforcing its position as a global leader in providing exceptional quality care. It enhances the country’s competitive edge in international health indicators and showcases its ability to attract cutting-edge medical technologies.
This initiative from Unilabs also reflects the UAE’s commitment to fostering an environment that attracts global companies, solidifying its status as a hub for healthcare innovation and excellence.
Through such advancements, the UAE continues to strengthen the quality of life for its residents and deliver world-class healthcare services, contributing to the “We The UAE Vision 2031” and the Sustainable Development Goals.
Innovative Technology
Dr. Ali Bayoumi Medical Director, Unilabs Middle East Cluster, and Medical Director, Unilabs Global SBU Genetics & Pharma, stated: “We are excited to launch such an innovative technology, the first of its kind in the Middle East, in partnership with Cytomed, the authorized agent for Genius Digital Diagnostics in the UAE. This move reflects Unilabs’ steadfast commitment to adopting the latest medical innovations to enhance the quality of healthcare.”
Dr.Bayoumi stressed that the advanced AI technology significantly accelerates the processing of imaging data, reducing the time needed for cervical cancer diagnoses. This improvement enhances doctors’ efficiency and minimizes patient waiting times.
He emphasized that the advanced AI capabilities, combined with Unilabs’ highly skilled human expertise, enable accurate analysis of laboratory results and rapid diagnosis with unparalleled quality and reliability. The integration of cutting-edge technology and human proficiency not only improves operational efficiency but also raises the quality of care and services offered to patients.
Bayoumi added, “With this innovative AI-powered technology, we aim to support the health sector’s efforts in early detection of cervical cancer, thereby reinforcing the UAE’s position as a regional and global leader in utilizing emerging technologies for healthcare and diagnostics.”
Mr. Mohamed Meligy, General Manager of Cytomed, stated: “Our commitment to the UAE healthcare sector drives us to bring the best practices to improve both the longevity and quality of life for our patients. Through our collaboration with Unilabs, we are enhancing lab capabilities with cutting-edge AI technology provided by our partner Hologic, a global leader in women’s healthcare. This partnership enables the early detection of cervical cancer with the advanced AI ‘Genius Digital Cytology’ tool. This reflects our ongoing contribution to the advancement of women’s health, recognizing that women represent half of our society and play a crucial role in caring for the entire community. We will continue our relentless efforts to improve the healthcare environment in the UAE for the betterment of all.”
